Lipoproteins of gram-positive bacteria: Key players in the immune response and virulence

Microbiology and Molecular Biology Reviews

Volumn 80, Issue 3, 2016, Pages 891-903

  Nguyen, Minh Thu ^a   Götz, Friedrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL RNA; BACTERIAL VACCINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; LIPOPROTEIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNSATURATED FATTY ACID; VIRULENCE FACTOR;

BACTERIAL VIRULENCE; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREACTIVITY; INFLAMMATION; NONHUMAN; PROTEIN CARBOHYDRATE INTERACTION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; ANIMAL; CELL MEMBRANE; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MOUSE; PATHOGENICITY; PHYSIOLOGY;

ANIMALS; CELL MEMBRANE; GRAM-POSITIVE BACTERIA; HUMANS; INFLAMMATION; LIPOPROTEINS; MICE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; VIRULENCE FACTORS;

EID: 84991207989     PISSN: 10922172     EISSN: 10985557     Source Type: Journal    
DOI: 10.1128/MMBR.00028-16     Document Type: Review

References (129)

1. 2+-bound structures reveal ligandbinding properties of SitA from the pathogen Staphylococcus pseudintermedius. Biosci Rep 34:e00154. http://dx.doi.org/10.1042/BSR20140088.
2. Braun V, Rehn K. 1969. Chemical characterization, spatial distribution and function of a lipoprotein (murein-lipoprotein) of the E. coli cell wall. The specific effect of trypsin on the membrane structure. Eur J Biochem 10:426-438.
3. Braun V, Wolff H. 1970. The murein-lipoprotein linkage in the cell wall of Escherichia coli. Eur J Biochem 14:387-391. http://dx.doi.org/10.1111/j.1432-1033.1970.tb00301.x.
4. Hantke K, Braun V. 1973. Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the N-terminal end of the mureinlipoprotein of the Escherichia coli outer membrane. Eur J Biochem 34:284-296.
5. Hayashi S, Wu HC. 1990. Lipoproteins in bacteria. J Bioenerg Biomembr 22:451-471. http://dx.doi.org/10.1007/BF00763177.
6. Lee PA, Tullman-Ercek D, Georgiou G. 2006. The bacterial twinarginine translocation pathway. Annu Rev Microbiol 60:373-395. http://dx.doi.org/10.1146/annurev. micro.60.080805.142212.
7. Tokunaga M, Tokunaga H, Wu HC. 1982. Post-translational modification and processing of Escherichia coli prolipoprotein in vitro. Proc Natl Acad Sci U S A 79:2255-2259. http://dx.doi.org/10.1073/pnas.79.7.2255.
8. Hussain M, Ichihara S, Mizushima S. 1982. Mechanism of signal peptide cleavage in the biosynthesis of the major lipoprotein of the Escherichia coli outer membrane. J Biol Chem 257:5177-5182.
9. Sankaran K, Gupta SD, Wu HC. 1995. Modification of bacterial lipoproteins. Methods Enzymol 250:683-697. http://dx.doi.org/10.1016/0076-6879 (95) 50105-3.
10. Buddelmeijer N. 2015. The molecular mechanism of bacterial lipoprotein modification-how, when and why? FEMS Microbiol Rev 39:246-261. http://dx.doi.org/10.1093/femsre/fuu006.
11. Schmollinger M, Fischer I, Nerz C, Pinkenburg S, Götz F, Kaufmann M, Lange KJ, Reuter R, Rosenstiel W, Zell A. 2004. ParSeq: searching motifs with structural and biochemical properties. Bioinformatics 20:1459-1461. http://dx.doi.org/10.1093/bioinformatics/bth083.
12. Stoll H, Dengjel J, Nerz C, Götz F. 2005. Staphylococcus aureus deficient in lipidation of prelipoproteins is attenuated in growth and immune activation. Infect Immun 73:2411-2423. http://dx.doi.org/10.1128/IAI.73.4.2411-2423.2005.
13. Kurokawa K, Lee H, Roh KB, Asanuma M, Kim YS, Nakyama H, Shiratsuchi A, Choi Y, Takeuchi O, Kang HJ, Dohmae N, Nakanishi Y, Akira S, Sekimizu K, Lee BL. 2009. The triacylated ATP binding cluster transporter substrate-binding lipoprotein of Staphylococcus aureus functions as a native ligand for the Toll-like receptor 2. J Biol Chem 284:8406-8411. http://dx.doi.org/10.1074/jbc. M809618200.
14. Müller P, Müller-Anstett M, Wagener J, Gao Q, Kaesler S, Schaller M, Biedermann T, Götz F. 2010. The Staphylococcus aureus lipoprotein SitC colocalizes with Toll-like receptor 2 (TLR2) in murine keratinocytes and elicits intracellular TLR2 accumulation. Infect Immun 78:4243-4250. http://dx.doi.org/10.1128/IAI.00538-10.
15. Kurokawa K, Kim MS, Ichikawa R, Ryu KH, Dohmae N, Nakayama H, Lee BL. 2012. Environment-mediated accumulation of diacyl lipoproteins over their triacyl counterparts in Staphylococcus aureus. J Bacteriol 194:3299-3306. http://dx.doi.org/10.1128/JB.00314-12.
16. Kurokawa K, Ryu KH, Ichikawa R, Masuda A, Kim MS, Lee H, Chae JH, Shimizu T, Saitoh T, Kuwano K, Akira S, Dohmae N, Nakayama H, Lee BL. 2012. Novel bacterial lipoprotein structures conserved in low-GC content gram-positive bacteria are recognized by Toll-like receptor 2. J Biol Chem 287:13170-13181. http://dx.doi.org/10.1074/jbc. M111.292235.
17. Schmaler M, Jann NJ, Ferracin F, Landolt LZ, Biswas L, Götz F, Landmann R. 2009. Lipoproteins in Staphylococcus aureus mediate inflammation by TLR2 and iron-dependent growth in vivo. J Immunol 182:7110-7118. http://dx.doi.org/10.4049/jimmunol.0804292.
18. Schmaler M, Jann NJ, Götz F, Landmann R. 2010. Staphylococcal lipoproteins and their role in bacterial survival in mice. Int J Med Microbiol 300:155-160. http://dx.doi.org/10.1016/j.ijmm.2009.08.018.
19. Bubeck Wardenburg J, Williams WA, Missiakas D. 2006. Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins. Proc Natl Acad Sci U S A 103:13831-13836. http://dx.doi.org/10.1073/pnas.0603072103.
20. Sander P, Rezwan M, Walker B, Rampini SK, Kroppenstedt RM, Ehlers S, Keller C, Keeble JR, Hagemeier M, Colston MJ, Springer B, Böttger EC. 2004. Lipoprotein processing is required for virulence of Mycobacterium tuberculosis. Mol Microbiol 52:1543-1552. http://dx.doi.org/10.1111/j.1365-2958.2004.04041.x.
21. Khandavilli S, Homer KA, Yuste J, Basavanna S, Mitchell T, Brown JS. 2008. Maturation of Streptococcus pneumoniae lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulence. Mol Microbiol 67:541-557. http://dx.doi.org/10.1111/j.1365-2958.2007.06065.x.
22. Petit CM, Brown JR, Ingraham K, Bryant AP, Holmes DJ. 2001. Lipid modification of prelipoproteins is dispensable for growth in vitro but essential for virulence in Streptococcus pneumoniae. FEMS Microbiol Lett 200:229-233. http://dx.doi.org/10.1111/j.1574-6968.2001.tb10720.x.
23. Bray BA, Sutcliffe IC, Harrington DJ. 2009. Impact of lgt mutation on lipoprotein biosynthesis and in vitro phenotypes of Streptococcus agalactiae. Microbiology 155:1451-1458. http://dx.doi.org/10.1099/mic.0.025213-0.
24. Henneke P, Dramsi S, Mancuso G, Chraibi K, Pellegrini E, Theilacker C, Hubner J, Santos-Sierra S, Teti G, Golenbock DT, Poyart C, Trieu-Cuot P. 2008. Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis. J Immunol 180:6149-6158. http://dx.doi.org/10.4049/jimmunol.180.9.6149.
25. Hamilton A, Robinson C, Sutcliffe IC, Slater J, Maskell DJ, Davis-Poynter N, Smith K, Waller A, Harrington DJ. 2006. Mutation of the maturase lipoprotein attenuates the virulence of Streptococcus equi to a greater extent than does loss of general lipoprotein lipidation. Infect Immun 74:6907-6919. http://dx.doi.org/10.1128/IAI.01116-06.
26. Weston BF, Brenot A, Caparon MG. 2009. The metal homeostasis protein, Lsp, of Streptococcus pyogenes is necessary for acquisition of zinc and virulence. Infect Immun 77:2840-2848. http://dx.doi.org/10.1128/IAI.01299-08.
27. Baumgartner M, Karst U, Gerstel B, Loessner M, Wehland J, Jansch L. 2007. Inactivation of Lgt allows systematic characterization of lipoproteins from Listeria monocytogenes. J Bacteriol 189:313-324. http://dx.doi.org/10.1128/JB.00976-06.
28. Machata S, Tchatalbachev S, Mohamed W, Jansch L, Hain T, Chakraborty T. 2008. Lipoproteins of Listeria monocytogenes are critical for virulence and TLR2-mediated immune activation. J Immunol 181:2028-2035. http://dx.doi.org/10.4049/jimmunol.181.3.2028.
29. Takeuchi O, Hoshino K, Akira S. 2000. TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J Immunol 165:5392-5396. http://dx.doi.org/10.4049/jimmunol.165.10.5392.
30. Yimin Kohanawa M, Zhao S, Ozaki M, Haga S, Nan G, Kuge Y, Tamaki N. 2013. Contribution of Toll-like receptor 2 to the innate response against Staphylococcus aureus infection in mice. PLoS One 8:e74287. http://dx.doi.org/10.1371/journal.pone.0074287.
31. Miller LS, O'Connell RM, Gutierrez MA, Pietras EM, Shahangian A, Gross CE, Thirumala A, Cheung AL, Cheng G, Modlin RL. 2006. MyD88 mediates neutrophil recruitment initiated by IL-1R but not TLR2 activation in immunity against Staphylococcus aureus. Immunity 24:79-91. http://dx.doi.org/10.1016/j.immuni.2005.11.011.
32. Molne L, Verdrengh M, Tarkowski A. 2000. Role of neutrophil leukocytes in cutaneous infection caused by Staphylococcus aureus. Infect Immun 68:6162-6167. http://dx.doi.org/10.1128/IAI.68.11.6162-6167.2000.
33. Verdrengh M, Tarkowski A. 1997. Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus. Infect Immun 65:2517-2521.
34. Miller LS, Pietras EM, Uricchio LH, Hirano K, Rao S, Lin H, O'Connell RM, Iwakura Y, Cheung AL, Cheng G, Modlin RL. 2007. Inflammasome-mediated production of IL-1beta is required for neutrophil recruitment against Staphylococcus aureus in vivo. J Immunol 179:6933-6942. http://dx.doi.org/10.4049/jimmunol.179.10.6933.
35. Kim J, Yang J, Park OJ, Kang SS, Kim WS, Kurokawa K, Yun CH, Kim HH, Lee BL, Han SH. 2013. Lipoproteins are an important bacterial component responsible for bone destruction through the induction of osteoclast differentiation and activation. J Bone Miner Res 28:2381-2391. http://dx.doi.org/10.1002/jbmr.1973.
36. Kim NJ, Ahn KB, Jeon JH, Yun CH, Finlay BB, Han SH. 2015. Lipoprotein in the cell wall of Staphylococcus aureus is a major inducer of nitric oxide production in murine macrophages. Mol Immunol 65:17-24. http://dx.doi.org/10.1016/j.molimm.2014.12.016.
37. Kang SS, Noh SY, Park OJ, Yun CH, Han SH. 2015. Staphylococcus aureus induces IL-8 expression through its lipoproteins in the human intestinal epithelial cell, Caco-2. Cytokine 75:174-180. http://dx.doi.org/10.1016/j.cyto.2015.04.017.
38. Chimalapati S, Cohen JM, Camberlein E, MacDonald N, Durmort C, Vernet T, Hermans PW, Mitchell T, Brown JS. 2012. Effects of deletion of the Streptococcus pneumoniae lipoprotein diacylglyceryl transferase gene lgt on ABC transporter function and on growth in vivo. PLoS One 7:e41393. http://dx.doi.org/10.1371/journal.pone.0041393.
39. Tomlinson G, Chimalapati S, Pollard T, Lapp T, Cohen J, Camberlein E, Stafford S, Periselneris J, Aldridge C, Vollmer W, Picard C, Casanova JL, Noursadeghi M, Brown J. 2014. TLR-mediated inflammatory responses to Streptococcus pneumoniae are highly dependent on surface expression of bacterial lipoproteins. J Immunol 193:3736-3745. http://dx.doi.org/10.4049/jimmunol.1401413.
40. Li N, Yang XY, Guo Z, Zhang J, Cao K, Han J, Zhang G, Liu L, Sun X, He QY. 2014. Varied metal-binding properties of lipoprotein PsaA in Streptococcus pneumoniae. J Biol Inorg Chem 19:829-838. http://dx.doi.org/10.1007/s00775-014-1114-9.
41. Johnston JW, Myers LE, Ochs MM, Benjamin WH, Jr, Briles DE, Hollingshead SK. 2004. Lipoprotein PsaA in virulence of Streptococcus pneumoniae: surface accessibility and role in protection from superoxide. Infect Immun 72:5858-5867. http://dx.doi.org/10.1128/IAI.72.10.5858-5867.2004.
42. Saleh M, Bartual SG, Abdullah MR, Jensch I, Asmat TM, Petruschka L, Pribyl T, Gellert M, Lillig CH, Antelmann H, Hermoso JA, Hammerschmidt S. 2013. Molecular architecture of Streptococcus pneumoniae surface thioredoxin-fold lipoproteins crucial for extracellular oxidative stress resistance and maintenance of virulence. EMBO Mol Med 5:1852-1870. http://dx.doi.org/10.1002/emmm.201202435.
43. Biswas L, Biswas R, Nerz C, Ohlsen K, Schlag M, Schafer T, Lamkemeyer T, Ziebandt AK, Hantke K, Rosenstein R, Gotz F. 2009. Role of the twin-arginine translocation pathway in Staphylococcus. J Bacteriol 191:5921-5929. http://dx.doi.org/10.1128/JB.00642-09.
44. Reffuveille F, Serror P, Chevalier S, Budin-Verneuil A, Ladjouzi R, Bernay B, Auffray Y, Rince A. 2012. The prolipoprotein diacylglyceryl transferase (Lgt) of Enterococcus faecalis contributes to virulence. Microbiology 158:816-825. http://dx.doi.org/10.1099/mic.0.055319-0.
45. Okugawa S, Moayeri M, Pomerantsev AP, Sastalla I, Crown D, Gupta PK, Leppla SH. 2012. Lipoprotein biosynthesis by prolipoprotein diacylglyceryl transferase is required for efficient spore germination and full virulence of Bacillus anthracis. Mol Microbiol 83:96-109. http://dx.doi.org/10.1111/j.1365-2958.2011.07915.x.
46. Charlton TM, Kovacs-Simon A, Michell SL, Fairweather NF, Tate EW. 2015. Quantitative lipoproteomics in Clostridium difficile reveals a role for lipoproteins in sporulation. Chem Biol 22:1562-1573. http://dx.doi.org/10.1016/j.chembiol.2015.10.006.
47. Tsuru T, Kobayashi I. 2008. Multiple genome comparison within a bacterial species reveals a unit of evolution spanning two adjacent genes in a tandem paralog cluster. Mol Biol Evol 25:2457-2473. http://dx.doi.org/10.1093/molbev/msn192.
48. Rosenstein R, Nerz C, Biswas L, Resch A, Raddatz G, Schuster SC, Götz F. 2009. Genome analysis of the meat starter culture bacterium Staphylococcus carnosus TM300. Appl Environ Microbiol 75:811-822. http://dx.doi.org/10.1128/AEM.01982-08.
49. Babu MM, Priya ML, Selvan AT, Madera M, Gough J, Aravind L, Sankaran K. 2006. A database of bacterial lipoproteins (DOLOP) with functional assignments to predicted lipoproteins. J Bacteriol 188:2761-2773. http://dx.doi.org/10.1128/JB.188.8.2761-2773.2006.
50. Nguyen MT, Kraft B, Yu W, Demicrioglu DD, Hertlein T, Burian M, Schmaler M, Boller K, Bekeredjian-Ding I, Ohlsen K, Schittek B, Götz F. 2015. The νSaα specific lipoprotein like cluster (lpl) of S. aureus USA300 contributes to immune stimulation and invasion in human cells. PLoS Pathog 11:e1004984. http://dx.doi.org/10.1371/journal.ppat.1004984.
51. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285:736-739. http://dx.doi.org/10.1126/science.285.5428.736.
52. Rawadi G, Garcia J, Lemercier B, Roman-Roman S. 1999. Signal transduction pathways involved in the activation of NF-kappa B, AP-1, and c-fos by Mycoplasma fermentans membrane lipoproteins in macrophages. J Immunol 162:2193-2203.
53. Norgard MV, Arndt LL, Akins DR, Curetty LL, Harrich DA, Radolf JD. 1996. Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B. Infect Immun 64:3845-3852.
54. Bulut Y, Faure E, Thomas L, Equils O, Arditi M. 2001. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface proteinAlipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Tolllike receptor 2 signaling. J Immunol 167:987-994. http://dx.doi.org/10.4049/jimmunol.167.2.987.
55. Takeuchi O, Kawai T, Muhlradt PF, Morr M, Radolf JD, Zychlinsky A, Takeda K, Akira S. 2001. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 13:933-940. http://dx.doi.org/10.1093/intimm/13.7.933.
56. Takeuchi O, Sato S, Horiuchi T, Hoshino K, Takeda K, Dong Z, Modlin RL, Akira S. 2002. Role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169:10-14. http://dx.doi.org/10.4049/jimmunol.169.1.10.
57. Takeda K, Takeuchi O, Akira S. 2002. Recognition of lipopeptides by Toll-like receptors. J Endotoxin Res 8:459-463.
58. Li J, Lee DS, Madrenas J. 2013. Evolving bacterial envelopes and plasticity of TLR2-dependent responses: basic research and translational opportunities. Front Immunol 4:347. http://dx.doi.org/10.3389/fimmu.2013.00347.
59. Takeda K, Akira S. 2004. TLR signaling pathways. Semin Immunol 16:3-9. http://dx.doi.org/10.1016/j.smim.2003.10.003.
60. Horng T, Barton GM, Flavell RA, Medzhitov R. 2002. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 420:329-333. http://dx.doi.org/10.1038/nature01180.
61. Verstak B, Nagpal K, Bottomley SP, Golenbock DT, Hertzog PJ, Mansell A. 2009. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses. J Biol Chem 284:24192-24203. http://dx.doi.org/10.1074/jbc. M109.023044.
62. Lin SC, Lo YC, Wu H. 2010. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465:885-890. http://dx.doi.org/10.1038/nature09121.
63. Kawasaki T, Kawai T. 2014. Toll-like receptor signaling pathways. Front Immunol 5:461. http://dx.doi.org/10.3389/fimmu.2014.00461.
64. Akira S, Uematsu S, Takeuchi O. 2006. Pathogen recognition and innate immunity. Cell 124:783-801. http://dx.doi.org/10.1016/j.cell.2006.02.015.
65. Morath S, Geyer A, Hartung T. 2001. Structure-function relationship of cytokine induction by lipoteichoic acid from Staphylococcus aureus. J Exp Med 193:393-397. http://dx.doi.org/10.1084/jem.193.3.393.
66. Morath S, Stadelmaier A, Geyer A, Schmidt RR, Hartung T. 2002. Synthetic lipoteichoic acid from Staphylococcus aureus is a potent stimulus of cytokine release. J Exp Med 195:1635-1640. http://dx.doi.org/10.1084/jem.20020322.
67. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274:17406-17409. http://dx.doi.org/10.1074/jbc.274.25.17406.
68. Hashimoto M, Tawaratsumida K, Kariya H, Kiyohara A, Suda Y, Krikae F, Kirikae T, Götz F. 2006. Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in Staphylococcus aureus. J Immunol 177:3162-3169. http://dx.doi.org/10.4049/jimmunol.177.5.3162.
69. Hashimoto M, Yasuoka J, Suda Y, Takada H, Yoshida T, Kotani S, Kusumoto S. 1997. Structural feature of the major but not cytokineinducing molecular species of lipoteichoic acid. J Biochem 121:779-786. http://dx.doi.org/10.1093/oxfordjournals.jbchem.a021653.
70. Takada H, Kawabata Y, Arakaki R, Kusumoto S, Fukase K, Suda Y, Yoshimura T, Kokeguchi S, Kato K, Komuro T, et al. 1995. Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities. Infect Immun 63:57-65.
71. Hashimoto M, Tawaratsumida K, Kariya H, Aoyama K, Tamura T, Suda Y. 2006. Lipoprotein is a predominant Toll-like receptor 2 ligand in Staphylococcus aureus cell wall components. Int Immunol 18:355-362.
72. Jimenez-Dalmaroni MJ, Radcliffe CM, Harvey DJ, Wormald MR, Verdino P, Ainge GD, Larsen DS, Painter GF, Ulevitch R, Beutler B, Rudd PM, Dwek RA, Wilson IA. 2015. Soluble human TLR2 ectodomain binds diacylglycerol from microbial lipopeptides and glycolipids. Innate Immun 21:175-193. http://dx.doi.org/10.1177/1753425914524077.
73. Buwitt-Beckmann U, Heine H, Wiesmuller KH, Jung G, Brock R, Akira S, Ulmer AJ. 2006. TLR1- and TLR6-independent recognition of bacterial lipopeptides. J Biol Chem 281:9049-9057. http://dx.doi.org/10.1074/jbc. M512525200.
74. Zähringer U, Lindner B, Inamura S, Heine H, Alexander C. 2008. TLR2-promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity. Immunobiology 213:205-224. http://dx.doi.org/10.1016/j.imbio.2008.02.005.
75. Koymans KJ, Feitsma LJ, Brondijk TH, Aerts PC, Lukkien E, Lossl P, Van Kessel KP, De Haas CJ, Van Strijp JA, Huizinga EG. 2015. Structural basis for inhibition of TLR2 by staphylococcal superantigen-like protein 3 (SSL3). Proc Natl Acad Sci U S A 112:11018-11023. http://dx.doi.org/10.1073/pnas.1502026112.
76. Bera A, Herbert S, Jakob A, Vollmer W, Götz F. 2005. Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan Oacetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol 55:778-787.
77. Bera A, Biswas R, Herbert S, Götz F. 2006. The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect Immun 74:4598-4604. http://dx.doi.org/10.1128/IAI.00301-06.
78. Shimada T, Park BG, Wolf AJ, Brikos C, Goodridge HS, Becker CA, Reyes CN, Miao EA, Aderem A, Götz F, Liu GY, Underhill DM. 2010. Staphylococcus aureus evades lysozyme-based peptidoglycan digestion that links phagocytosis, inflammasome activation, and IL-1beta secretion. Cell Host Microbe 7:38-49. http://dx.doi.org/10.1016/j.chom.2009.12.008.
79. Reddick LE, Alto NM. 2014. Bacteria fighting back: how pathogens target and subvert the host innate immune system. Mol Cell 54:321-328. http://dx.doi.org/10.1016/j.molcel.2014.03.010.
80. Skabytska Y, Wolbing F, Gunther C, Koberle M, Kaesler S, Chen KM, Guenova E, Demircioglu D, Kempf WE, Volz T, Rammensee HG, Schaller M, Röcken M, Götz F, Biedermann T. 2014. Cutaneous innate immune sensing of Toll-like receptor 2-6 ligands suppresses T cell immunity by inducing myeloid-derived suppressor cells. Immunity 41:762-775. http://dx.doi.org/10.1016/j.immuni.2014.10.009.
81. Bekeredjian-Ding I, Inamura S, Giese T, Moll H, Endres S, Sing A, Zähringer U, Hartmann G. 2007. Staphylococcus aureus protein A triggers T cell-independent B cell proliferation by sensitizing B cells for TLR2 ligands. J Immunol 178:2803-2812. http://dx.doi.org/10.4049/jimmunol.178.5.2803.
82. Parcina M, Miranda-Garcia MA, Durlanik S, Ziegler S, Over B, Georg P, Foermer S, Ammann S, Hilmi D, Weber KJ, Schiller M, Heeg K, Schneider-Brachert W, Götz F, Bekeredjian-Ding I. 2013. Pathogentriggered activation of plasmacytoid dendritic cells induces IL-10-producing B cells in response to Staphylococcus aureus. J Immunol 190:1591-1602. http://dx.doi.org/10.4049/jimmunol.1201222.
83. Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE. 2014. NOD proteins: regulators of inflammation in health and disease. Nat Rev Immunol 14:9-23. http://dx.doi.org/10.1038/nri3565.
84. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jehanno M, Viala J, Tedin K, Taha MK, Labigne A, Zahringer U, Coyle AJ, DiStefano PS, Bertin J, Sansonetti PJ, Philpott DJ. 2003. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300:1584-1587. http://dx.doi.org/10.1126/science.1084677.
85. Müller-Anstett MA, Müller P, Albrecht T, Nega M, Wagener J, Gao Q, Kaesler S, Schaller M, Biedermann T, Götz F. 2010. Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes. PLoS One 5:e13153. http://dx.doi.org/10.1371/journal.pone.0013153.
86. Volz T, Nega M, Buschmann J, Kaesler S, Guenova E, Peschel A, Röcken M, Götz F, Biedermann T. 2010. Natural Staphylococcus aureusderived peptidoglycan fragments activate NOD2 and act as potent costimulators of the innate immune system exclusively in the presence of TLR signals. FASEB J http://dx.doi.org/1096/fj.09-151001.
87. Schäffler H, Demircioglu DD, Kuhner D, Menz S, Bender A, Autenrieth IB, Bodammer P, Lamprecht G, Götz F, Frick JS. 2014. NOD2 stimulation by Staphylococcus aureus-derived peptidoglycan is boosted by Toll-like receptor 2 costimulation with lipoproteins in dendritic cells. Infect Immun 82:4681-4688. http://dx.doi.org/10.1128/IAI.02043-14.
88. Iyer JK, Coggeshall KM. 2011. Primary innate immune cells respond efficiently to polymeric peptidoglycan, but not to peptidoglycan monomers. J Immunol 186:3841-3845. http://dx.doi.org/10.4049/jimmunol.1004058.
89. Gutierrez O, Pipaon C, Inohara N, Fontalba A, Ogura Y, Prosper F, Nunez G, Fernandez-Luna JL. 2002. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J Biol Chem 277:41701-41705. http://dx.doi.org/10.1074/jbc. M206473200.
90. Rosenstiel P, Fantini M, Brautigam K, Kuhbacher T, Waetzig GH, Seegert D, Schreiber S. 2003. TNF-alpha and IFN-gamma regulate the expression of the NOD2 (CARD15) gene in human intestinal epithelial cells. Gastroenterology 124:1001-1009. http://dx.doi.org/10.1053/gast.2003.50157.
91. Mauthe, M, Yu, W, Krut, O., Kronke, M, Götz, F, Robenek, H, Proikas-Cezanne, T. 2012. WIPI-1 positive autophagosome-like vesicles entrap pathogenic Staphylococcus aureus for lysosomal degradation. Int J Cell Biol 2012:179207. http://dx.doi.org/10.1155/2012/179207.
92. Philpott DJ, Girardin SE. 2010. Nod-like receptors: sentinels at host membranes. Curr Opin Immunol 22:428-434. http://dx.doi.org/10.1016/j.coi.2010.04.010.
93. Dalmasso G, Nguyen HT, Charrier-Hisamuddin L, Yan Y, Laroui H, Demoulin B, Sitaraman SV, Merlin D. 2010. PepT1 mediates transport of the proinflammatory bacterial tripeptide L-Ala-D-Glu-meso-DAP in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 299:G687-696. http://dx.doi.org/10.1152/ajpgi.00527.2009.
94. Chiu YC, Lin CY, Chen CP, Huang KC, Tong KM, Tzeng CY, Lee TS, Hsu HC, Tang CH. 2009. Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1-dependent pathway. J Immunol 183:2785-2792. http://dx.doi.org/10.4049/jimmunol.0802826.
95. Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, Janeway CA, Medzhitov R, Flavell RA. 2002. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416:194-199. http://dx.doi.org/10.1038/416194a.
96. Wang K, Mahmud H, Foller M, Biswas R, Lang KS, Bohn E, Götz F, Lang F. 2008. Lipopeptides in the triggering of erythrocyte cell membrane scrambling. Cell Physiol Biochem 22:381-386. http://dx.doi.org/10.1159/000187116.
97. Gurtler C, Bowie AG. 2013. Innate immune detection of microbial nucleic acids. Trends Microbiol 21:413-420. http://dx.doi.org/10.1016/j.tim.2013.04.004.
98. Kawasaki T, Kawai T, Akira S. 2011. Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity. Immunol Rev 243:61-73. http://dx.doi.org/10.1111/j.1600-065X.2011.01048.x.
99. Bergstrom B, Aune MH, Awuh JA, Kojen JF, Blix KJ, Ryan L, Flo TH, Mollnes TE, Espevik T, Stenvik J. 2015. TLR8 senses Staphylococcus aureus RNA in human primary monocytes and macrophages and induces IFN-beta production via a TAK1-IKKbeta-IRF5 signaling pathway. J Immunol http://dx.doi.org/10.4049/jimmunol.1403176.
100. Ishii N, Funami K, Tatematsu M, Seya T, Matsumoto M. 2014. Endosomal localization of TLR8 confers distinctive proteolytic processing on human myeloid cells. J Immunol 193:5118-5128. http://dx.doi.org/10.4049/jimmunol.1401375.
101. Triantafilou M, Gamper FG, Haston RM, Mouratis MA, Morath S, Hartung T, Triantafilou K. 2006. Membrane sorting of Toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J Biol Chem 281:31002-31011. http://dx.doi.org/10.1074/jbc. M602794200.
102. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, Endres S, Hartmann G. 2002. Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168:4531-4537. http://dx.doi.org/10.4049/jimmunol.168.9.4531.
103. Kagan JC, Su T, Horng T, Chow A, Akira S, Medzhitov R. 2008. TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferonbeta. Nat Immunol 9:361-368. http://dx.doi.org/10.1038/ni1569.
104. Husebye H, Aune MH, Stenvik J, Samstad E, Skjeldal F, Halaas O, Nilsen NJ, Stenmark H, Latz E, Lien E, Mollnes TE, Bakke O, Espevik T. 2010. The Rab11a GTPase controls Toll-like receptor 4-induced activation of interferon regulatory factor-3 on phagosomes. Immunity 33:583-596. http://dx.doi.org/10.1016/j.immuni.2010.09.010.
105. Deshmukh SD, Kremer B, Freudenberg M, Bauer S, Golenbock DT, Henneke P. 2011. Macrophages recognize streptococci through bacterial single-stranded RNA. EMBO Rep 12:71-76. http://dx.doi.org/10.1038/embor.2010.189.
106. Mancuso G, Gambuzza M, Midiri A, Biondo C, Papasergi S, Akira S, Teti G, Beninati C. 2009. Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat Immunol 10:587-594. http://dx.doi.org/10.1038/ni.1733.
107. Gratz N, Hartweger H, Matt U, Kratochvill F, Janos M, Sigel S, Drobits B, Li XD, Knapp S, Kovarik P. 2011. Type I interferon production induced by Streptococcus pyogenes-derived nucleic acids is required for host protection. PLoS Pathog 7:e1001345. http://dx.doi.org/10.1371/journal.ppat.1001345.
108. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339:520-532. http://dx.doi.org/10.1056/NEJM199808203390806.
109. Do TQ, Moshkani S, Castillo P, Anunta S, Pogosyan A, Cheung A, Marbois B, Faull KF, Ernst W, Chiang SM, Fujii G, Clarke CF, Foster K, Porter E. 2008. Lipids including cholesteryl linoleate and cholesteryl arachidonate contribute to the inherent antibacterial activity of human nasal fluid. J Immunol 181:4177-4187. http://dx.doi.org/10.4049/jimmunol.181.6.4177.
110. Lampe MA, Burlingame AL, Whitney J, Williams ML, Brown BE, Roitman E, Elias PM. 1983. Human stratum corneum lipids: characterization and regional variations. J Lipid Res 24:120-130.
111. Wille JJ, Kydonieus A. 2003. Palmitoleic acid isomer (C16:1delta6) in human skin sebum is effective against gram-positive bacteria. Skin Pharmacol Appl Skin Physiol 16:176-187. http://dx.doi.org/10.1159/000069757.
112. Arsic B, Zhu Y, Heinrichs DE, McGavin MJ. 2012. Induction of the staphylococcal proteolytic cascade by antimicrobial fatty acids in community acquired methicillin resistant Staphylococcus aureus. PLoS One 7:e45952. http://dx.doi.org/10.1371/journal.pone.0045952.
113. Kenny JG, Ward D, Josefsson E, Jonsson IM, Hinds J, Rees HH, Lindsay JA, Tarkowski A, Horsburgh MJ. 2009. The Staphylococcus aureus response to unsaturated long chain free fatty acids: survival mechanisms and virulence implications. PLoS One 4:e4344. http://dx.doi.org/10.1371/journal.pone.0004344.
114. White DC, Frerman FE. 1968. Fatty acid composition of the complex lipids of Staphylococcus aureus during the formation of the membranebound electron transport system. J Bacteriol 95:2198-2209.
115. Parsons JB, Broussard TC, Bose JL, Rosch JW, Jackson P, Subramanian C, Rock CO. 2014. Identification of a two-component fatty acid kinase responsible for host fatty acid incorporation by Staphylococcus aureus. Proc Natl Acad Sci U S A 111:10532-10537. http://dx.doi.org/10.1073/pnas.1408797111.
116. Nguyen MT, Hanzelmann D, Hartner T, Peschel A, Götz F. 2016. Skin-specific unsaturated fatty acids boost the Staphylococcus aureus innate immune response. Infect Immun 84:205-215. http://dx.doi.org/10.1128/IAI.00822-15.
117. Sigal LH, Zahradnik JM, Lavin P, Patella SJ, Bryant G, Haselby R, Hilton E, Kunkel M, Adler-Klein D, Doherty T, Evans J, Molloy PJ, Seidner AL, Sabetta JR, Simon HJ, Klempner MS, Mays J, Marks D, Malawista SE. 1998. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium. N Engl J Med 339:216-222.
118. Steere AC, Sikand VK, Meurice F, Parenti DL, Fikrig E, Schoen RT, Nowakowski J, Schmid CH, Laukamp S, Buscarino C, Krause DS. 1998. Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med 339:209-215.
119. Foster TJ, Geoghegan JA, Ganesh VK, Höök M. 2014. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol 12:49-62. http://dx.doi.org/10.1038/nrmicro3161.
120. Kehl-Fie TE, Zhang Y, Moore JL, Farrand AJ, Hood MI, Rathi S, Chazin WJ, Caprioli RM, Skaar EP. 2013. MntABC and MntH contribute to systemic Staphylococcus aureus infection by competing with calprotectin for nutrient manganese. Infect Immun 81:3395-3405. http://dx.doi.org/10.1128/IAI.00420-13.
121. Cockayne A, Hill PJ, Powell NB, Bishop K, Sims C, Williams P. 1998. Molecular cloning of a 32-kilodalton lipoprotein component of a novel iron-regulated Staphylococcus epidermidis ABC transporter. Infect Immun 66:3767-3774.
122. Anderson AS, Scully IL, Timofeyeva Y, Murphy E, McNeil LK, Mininni T, Nunez L, Carriere M, Singer C, Dilts DA, Jansen KU. 2012. Staphylococcus aureus manganese transport protein C is a highly conserved cell surface protein that elicits protective immunity against S. aureus and Staphylococcus epidermidis. J Infect Dis 205:1688-1696. http://dx.doi.org/10.1093/infdis/jis272.
123. Gribenko A, Mosyak L, Ghosh S, Parris K, Svenson K, Moran J, Chu L, Li S, Liu T, Woods VL, Jr, Jansen KU, Green BA, Anderson AS, Matsuka YV. 2013. Three-dimensional structure and biophysical characterization of Staphylococcus aureus cell surface antigen-manganese transporter MntC. J Mol Biol 425:3429-3445. http://dx.doi.org/10.1016/j.jmb.2013.06.033.
124. Mariotti P, Malito E, Biancucci M, Lo Surdo P, Mishra RP, Nardi-Dei V, Savino S, Nissum M, Spraggon G, Grandi G, Bagnoli F, Bottomley MJ. 2013. Structural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2. Biochem J 449:683-693. http://dx.doi.org/10.1042/BJ20121426.
125. Podkowa KJ, Briere LA, Heinrichs DE, Shilton BH. 2014. Crystal and solution structure analysis of FhuD2 from Staphylococcus aureus in multiple unliganded conformations and bound to ferrioxamine-B. Biochemistry 53:2017-2031. http://dx.doi.org/10.1021/bi401349d.
126. Mishra RP, Mariotti P, Fiaschi L, Nosari S, Maccari S, Liberatori S, Fontana MR, Pezzicoli A, De Falco MG, Falugi F, Altindis E, Serruto D, Grandi G, Bagnoli F. 2012. Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice. J Infect Dis 206:1041-1049. http://dx.doi.org/10.1093/infdis/jis463.
127. Bagnoli F, Fontana MR, Soldaini E, Mishra RP, Fiaschi L, Cartocci E, Nardi-Dei V, Ruggiero P, Nosari S, De Falco MG, Lofano G, Marchi S, Galletti B, Mariotti P, Bacconi M, Torre A, Maccari S, Scarselli M, Rinaudo CD, Inoshima N, Savino S, Mori E, Rossi-Paccani S, Baudner B, Pallaoro M, Swennen E, Petracca R, Brettoni C, Liberatori S, Norais N, Monaci E, Bubeck Wardenburg J, Schneewind O, O'Hagan DT, Valiante NM, Bensi G, Bertholet S, De Gregorio E, Rappuoli R, Grandi G. 2015. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus. Proc Natl Acad SciUS A 112:3680-3685. http://dx.doi.org/10.1073/pnas.1424924112.
128. Schluepen C, Malito E, Marongiu A, Schirle M, McWhinnie E, Lo Surdo P, Biancucci M, Falugi F, Nardi-Dei V, Marchi S, Fontana MR, Lombardi B, De Falco MG, Rinaudo CD, Spraggon G, Nissum M, Bagnoli F, Grandi G, Bottomley MJ, Liberatori S. 2013. Mining the bacterial unknown proteome: identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureus. Biochem J 455:273-284. http://dx.doi.org/10.1042/BJ20130540.
129. Das S, Kanamoto T, Ge X, Xu P, Unoki T, Munro CL, Kitten T. 2009. Contribution of lipoproteins and lipoprotein processing to endocarditis virulence in Streptococcus sanguinis. J Bacteriol 191:4166-4179. http://dx.doi.org/10.1128/JB.01739-08.